Skip to content

XPEV

NYSE
Weak · 39/100

Xpeng Inc

Consumer Discretionary
Automobiles
Earnings Aug 19

$13.26

0.5%

Updated Today 3:42 PM ET

Report Card

XPEV at a glance — five pillars scored 0–100 from real filed financials.

Value
Growth
0
Profitability
0
Health
0
Dividends
0

Overall: Weak · 39/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.

Price — Past Year

▼ Down 28.1% over the last 12 months

Price 50-day average 200-day averageSource: Yahoo Finance · refreshed daily
Key Metrics

Market Cap

$13.04B

P/E

Forward P/E (est.)

ROE

-7.6%

Revenue Growth

47.5%

EPS Growth

Profit Margin

-3.1%

FCF Yield

Debt / Equity

1.12x

ROIC

-6.0%

Interest Coverage

Current Ratio

5.06x

Dividend Yield

Implied Growth (rev. DCF)

3.3%

Rating Score

39/100

Business Overview
Research

Xpeng Inc (XPEV) is a large-cap company in the Automobiles industry, part of the Consumer Discretionary sector of the S&P 500, with a market value around $13.04B.

In its latest reported year it generated about $10.74B in revenue and posted a net loss of $159.52M.

Our model rates XPEV Weak (39/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Economic Moat

Evidence of durable competitive advantage in the filed financials (8 years of history).

No moat evidenceMoat evidence score: 25/100

The numbers don't show a durable competitive advantage — margins, growth, or returns on capital have been unstable or thin. Great returns are still possible; they just aren't protected.

Gross margin level0/100

11.5% average over the last 3 years

Gross margin stability0/100

±15.9 pts around 1.9% across 8 years

Revenue durability100/100

grew in 7 of the last 7 year-over-year periods

Free-cash-flow consistency0/100

positive in 1 of 8 years

Return on invested capital0/100

-6.0% latest fiscal year

A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.

Technical Analysis (Educational)
Research

Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what XPEV's chart says today, with each tool explained.

Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. XPEV trades near $13.26, below its 50-day average ($15.19) and 200-day average ($18.82). Price below both averages is a downtrend — momentum is against buyers for now.

Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 41 it is in neutral territory — neither stretched nor washed out.

MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.

Volatility — ATR. Average True Range is the typical daily move. XPEV's is $0.57 (~4.3% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.

Support & resistance. Over the last month XPEV found buyers near $11.77 (support) and sellers near $16.60 (resistance); its 52-week range is $11.77–$28.24. A decisive break beyond either edge often marks the next move.

Volume. The latest session traded 0.6× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.

Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.

Revenue Growth
Research

4Y CAGR

38.3%

2/2 checks passedRevenue growingRevenue growth beats sector midpoint

Revenue moved from $1.36M in 2018 to $10.74B in 2025, a 260.4% compound annual growth rate. The most recent year grew a strong 47.5% year over year. Consistent top-line growth is one sign of healthy demand.

Profitability
Research
0/4 checks passedProfitableNet margin above sector midpointROE above 12%ROIC above 10%

Gross Margin

18.9%

Operating Margin

-3.6%

Net Margin

-1.5%

ROE

-7.6%

Xpeng Inc keeps about -3.1% of each sales dollar as net profit, with a 18.9% gross margin and -3.6% operating margin. Return on equity is -7.6% and return on invested capital about -6.0%. The company is currently unprofitable on a net basis.

Debt Analysis
Research
2/3 checks passedDebt under 1× equityDebt under 2× equityShort-term bills covered

Total Debt

$21.00M

Net Debt

-$4.46B

Net cash position

Net Debt / EBITDA

Debt / Equity

1.12x

Leverage: debt-to-equity is 1.1x, with a current ratio of 5.1x. That is a moderate, manageable debt load for most businesses. It carries roughly $21.00M of total debt against $4.48B of cash.

Cash Flow Analysis
Research
1/1 checks passedMarket expects achievable growth (<8%)

Operating CF

$1.16B

Free Cash Flow

$714.37M

FCF Margin

6.7%

In the latest year Xpeng Inc produced about $1.16B of operating cash flow and $714.37M of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.

Valuation Analysis
Research
1/1 checks passedTrading below DCF fair value

P/E

P/S

1.05x

P/B

4.35x

EV / EBITDA

XPEV trades at n/a trailing earnings, 1.0x sales, and 4.4x book value. Reverse-engineering today's price implies the market expects roughly 3.3% long-term free-cash-flow growth. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.

DCF Fair Value (Educational)

A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.

DCF fair value / share

Current price

$13.26

+127% · Below fair-value estimate

Starting FCF (latest 10-K)

$714.37M

Growth, years 1–5

20.0%

Fade to terminal, years 6–10

2.5%

Discount rate

9.0%

PV of 10-yr free cash flow$11.04B
PV of terminal value$18.54B
Estimated equity value$29.58B

Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.

Metrics vs. Sector Range

Where XPEV sits versus its Consumer Discretionary sector peers in the S&P 500.

TTM P/E
Forward P/E
P/S ratio
1.0xFair
Revenue growth
47.5%Strong
EPS growth
Gross margin
18.9%Weak
Net margin
-3.1%Weak
ROE
-7.6%Weak

Bands show the middle half (25th–75th percentile) of the 85 Consumer Discretionary companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.

Sector Peer Comparison

How XPEV stacks up against its Consumer Discretionary peers — valuation, profitability, and growth versus the sector median.

In the Consumer Discretionary sector (158 S&P 500 companies), XPEV ranks #64 of 158 by our overall rating.

P/E vs sector

median 25.1x

ROE vs sector

-7.6%

median 26.2%

Growth vs sector

47.5%

median 6.8%

Sector rank

#64

of 158 by rating

CompanyP/ERev Gr.Rating
XPEVThis stock47.5%Weak· 39
LI73.5x-24.4%Weak· 25
NIO48.8%Weak· 30
STLA15.3%Neutral· 57
HMC0.5%Weak· 14
RACE40.2x4.7%Neutral· 51
TM7.8x5.5%Weak· 37
LCIDNot rated
Consumer Discretionary median25.1x6.8%24/100

Valuation vs. quality map

sector medianLIRACETMP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Consumer Discretionary companies by sub-industry and size. Sector median is across all 158 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$0.00 $0.00

vs. $13.26 today · expected CAGR 14%26%

Metric20262027202820292030
Revenue$15.57B$22.58B$32.74B$47.48B$68.85B
Net income$467.22M$677.47M$982.34M$1.42B$2.07B
EPS$0.48$0.69$1.00$1.45$2.10
Share price (low)$5.70$8.27$11.99$17.38$25.21
Share price (high)$9.50$13.78$19.98$28.97$42.01
CAGR (low–high)-57% / -28%-21% / 2%-3% / 15%7% / 22%14% / 26%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for XPEV:

  • Revenue is growing 47.5% a year, a sign of real demand.
  • As an established S&P 500 member in Consumer Discretionary, it brings scale and a long operating history.
Bear Case

The case against XPEV:

  • Thin net margins (-3.1%) leave little room for error.
  • Our model's overall read is Weak (39/100).
Key Risks
Research

Balance-sheet risk — debt/equity of 1.1x magnifies the impact of higher rates or weaker earnings.

Margin risk — thin profitability (-3.1%) is vulnerable to cost or pricing pressure.

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the fundamentals screen weakly: Xpeng Inc is a large-cap consumer discretionary business still growing nicely, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Weak (39/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Analyst Ratings

What 33 Wall Street analysts covering XPEV recommend (July 2026). Consensus is a useful sanity check — not a substitute for your own homework.

Buy
consensus · score 3.9 / 5 across 33 analysts
Strong Buy 8Buy 17Hold 6Sell 2Strong Sell 0

Latest SEC Filings

XPEV's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.

XPEV — frequently asked questions

Is XPEV a good stock to buy?

We don't give buy or sell advice. Our model rates Xpeng Inc Weak (39/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.

What is XPEV's rating on The Stocks School?

Xpeng Inc currently scores 39/100 (Weak) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.

How our ratings work
Where does XPEV's data come from?

Live price data plus real fundamentals and 5-year financials pulled directly from Xpeng Inc's SEC filings — refreshed automatically, not hand-entered.

How is the 5-year projection for XPEV calculated?

It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.

Is this XPEV analysis financial advice?

No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell XPEV. Always do your own research and consider a licensed professional.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.